search

Active clinical trials for "Heart Diseases"

Results 1901-1910 of 3529

Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart...

Heart FailureCongenital Heart Disease

Paediatric clinical trial in 50 children, from newborn to less than 6 years of age, suffering from heart failure due to congenital heart disease, to obtain paediatric pharmacokinetic and pharmacodynamic data of enalapril and its active metabolite enalaprilat while treated for 8 weeks with enalapril in form of Orodispersible Minitablets (ODMTs), to describe the dose exposure in this patient population.

Unknown status23 enrollment criteria

Homebased Monitoring Cardiac Rehabilitation Program

Homebased Cardiac Rehabilitation Program After Ischemic Heart Disease

The current state of mobile communication and technology is a tool to support home programs for chronic disease management, useful to facilitate access to these types of programs, because the investigators could obtain telematics information about the parameters, reducing cardiovascular risk factors and cardiovascular morbidity and mortality.

Unknown status23 enrollment criteria

Randomized Anticoagulation Trial in Opcab (RATIO)

Ischemic Heart Disease

The RATIO Study is a multicenter, nationwide, randomized, controlled, single blinded, unfunded trial of n. 900 patients undergoing multivessel OPCAB (≥2 grafts). This study is designed to test in patients undergoing off-pump coronary artery bypass surgery the hypothesis that full (high dose, 300 U/kg) and half (low dose,150 U/kg) heparinization are not different in terms of thrombotic complications and major perioperative bleeding events (null hypothesis).

Unknown status2 enrollment criteria

Bifurcation ABSORB OCT Trial

Myocardial IschemiaIschemia8 more

The Bifurcation ABSORB OCT Trial is a prospective, randomized (1:1) evaluation of the efficacy and performance of single ABSORB everolimus eluting bioresorbable vascular scaffold provisional strategy in the treatment of (a) coronary bifurcation lesion(s) in consecutive subjects with and without fenestration towards the side branch. Patients included in this study will be divided into three different cohorts: Cohort A (patient 1-20): Angiographic FU with OCT at 12 months. Cohort B (patient 21-40): Angiographic FU with OCT at 24 months. Cohort C (patient 41-60): Angiographic FU with OCT at 36 months. All patients will also have telephone FU at 30 days, 12, 24 and 36 months. Inclusion of patients in the BISORB OCT trial stopped in November 2016 after safety concerns of the ABSORB BVS were reported. BISORB OCT included 3 patients, which were all included in the Academic Medical Center

Unknown status10 enrollment criteria

Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea

Ischemic Heart DiseaseAcute Myocardial Infarction

The purpose of this study is to evaluate the safety and clinical efficacy of VM202RY injected via transendocardial route using C-Cathez® catheter (Celyad, S.A., Belgium) in subjects with AMI. Stage 1: Evaluation of safety and tolerability of VM202RY injection Stage 2: Evaluation of safety and efficacy of VM202RY injection

Unknown status39 enrollment criteria

High Septal Pacing for Cardiac Resynchronization Therapy

Heart FailureLeft Bundle Branch Block1 more

The purpose of this acute study is to perform a preliminary investigation of high septal right ventricular pacing in the vicinity of the His bundle region as an alternate or adjunctive means for cardiac resynchronization in patients with heart failure and wide QRS.

Terminated17 enrollment criteria

Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease

Congenital Heart Disease

This study aims to examine performance on a neurological screening test, the Dubowitz, and sleep wake cycles on amplitude integrated electroencephalogram (AEEG) in neonates with congenital heart disease (CHD) as a way to potentially predict longterm motor outcome. It will compare the results of these studies to neonates without CHD.

Terminated9 enrollment criteria

Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease

Ischemic Heart Disease

To explore the safety and efficiency of adenovirus-hepatocyte growth factor(Ad-HGF) treatment in ischemic heart disease.

Unknown status14 enrollment criteria

The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization

Ischemic Heart DiseaseMyocardial Ischemia2 more

The study is a Prospective, Multi-center, Single Armed Registry to Evaluate The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization.

Unknown status19 enrollment criteria

BioFreedom US IDE Feasibility Trial

Ischemic Heart DiseaseStable Angina2 more

The purpose of this study is to collect additional safety and effectiveness data for on the Biosensors BioFreedom™ BA9 Drug Coated Coronary Stent in patients with native, de novo coronary artery disease.

Unknown status21 enrollment criteria
1...190191192...353

Need Help? Contact our team!


We'll reach out to this number within 24 hrs